Evaluation of JNK Blockade as an Early Intervention Treatment for Type 1 Diabetic Nephropathy in Hypertensive Rats

JNK signalling in human and experimental renal ischaemia/reperfusion injury

(2010) J. Kanellis et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Macrophages and Diabetic Nephropathy

(2010) Greg H. Tesch   SEMINARS IN NEPHROLOGY

Aldosterone-Induced Activation of Signaling Pathways Requires Activity of Angiotensin Type 1a Receptors

(2009) Catherine A. Lemarié et al.   CIRCULATION RESEARCH

Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice

(2009) A. K. H. Lim et al.   DIABETOLOGIA

c-Jun NH2-Terminal Kinase Is Crucially Involved in Renal Tubulo-Interstitial Inflammation

(2009) M. H. de Borst et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the rat

(2009) Frank Y Ma et al.   LABORATORY INVESTIGATION

Role of aldose reductase in the high glucose induced expression of fibronectin in human mesangial cells

(2009) Ping Huang et al.   MOLECULAR BIOLOGY REPORTS

Inhibition of C-jun N-terminal kinase improves insulin sensitivity but worsens albuminuria in experimental diabetes

(2008) Adeel Ijaz et al.   KIDNEY INTERNATIONAL

c-Jun amino terminal kinase 1 deficient mice are protected from streptozotocin-induced islet injury

(2007) Kyoichi Fukuda et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS